Consumption of medicinal plants by patients with heart diseases at a pharmacist-managed anticoagulation clinic in Brazil

被引:0
|
作者
Paula Mendonça Leite
Rachel Oliveira Castilho
Antonio Luiz Pinho Ribeiro
Maria Auxiliadora Parreiras Martins
机构
[1] Universidade Federal de Minas Gerais,
关键词
Anticoagulants; Heart diseases; Medicinal plants; Warfarin;
D O I
暂无
中图分类号
学科分类号
摘要
Background Medicinal plants (MP) have been used for many years with the purpose of feeding and curing. Several MP may interfere in drug response and are not always considered as potential drug-interactors in clinical practice. Objective To investigate the consumption of MP by outpatients during a one-year follow-up. Method Patients with cardiopathy diagnosis and indication(s) for long-term use of warfarin were recruited at a pharmacist-managed anticoagulation clinic of a Brazilian public hospital. This research employed a descriptive method. The consumption of MP was examined regarding the type, frequency and forms of use. Results A total of 280 patients were studied. Most patients were female (54.6 %) with an average age of 56.8 ± 13.1 years. The consumption of MP was reported by 46 (16.4 %) patients, totalizing 59 occurrences. Lemon, lemon balm and plantain were the most common MP. The main pharmacological uses involved the digestive, urinary, and respiratory tracts. Tea was the predominant form of consumption (87 %). Twelve (33.3 %) plants presented potential herb-warfarin interactions according to the literature. Conclusion We described the consumption of MP among outpatients characterized by their complex disease status, propensity for adverse events, and socioeconomic limitations. These results may guide pharmacist interventions and procedures to prevent clinical complications.
引用
收藏
页码:223 / 227
页数:4
相关论文
共 50 条
  • [1] Consumption of medicinal plants by patients with heart diseases at a pharmacist-managed anticoagulation clinic in Brazil
    Leite, Paula Mendonca
    Castilho, Rachel Oliveira
    Pinho Ribeiro, Antonio Luiz
    Parreiras Martins, Maria Auxiliadora
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 223 - 227
  • [2] EVALUATION OF A PHARMACIST-MANAGED ANTICOAGULATION CLINIC
    COHEN, IA
    HUTCHISON, TA
    KIRKING, DM
    SHUE, ME
    [J]. JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1985, 10 (02): : 167 - 175
  • [3] Interventions unrelated to anticoagulation in a pharmacist-managed anticoagulation clinic
    Hicho, Michael D.
    Rybarczyk, Amy
    Boros, Melanie
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (11) : S80 - S87
  • [4] RETROSPECTIVE EVALUATION OF A PHARMACIST-MANAGED WARFARIN ANTICOAGULATION CLINIC
    GARABEDIANRUFFALO, SM
    GRAY, DR
    SAX, MJ
    RUFFALO, RL
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (02): : 304 - 308
  • [5] Pharmacist-managed carvedilol heart failure clinic
    Darlington, MP
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (15) : 1626 - 1626
  • [6] Utility of a pharmacist-managed Anticoagulation Program in patients with congenital heart disease
    O'Neil, Meredith J.
    Garr, BreAnn N.
    Faircloth, Jenna M.
    Ciambarella, Julie A.
    Lubert, Adam M.
    Nelson, Nicole L.
    Cooper, David S.
    [J]. CARDIOLOGY IN THE YOUNG, 2024, 34 (03) : 628 - 633
  • [7] COST-JUSTIFICATION OF A CLINICAL PHARMACIST-MANAGED ANTICOAGULATION CLINIC
    GRAY, DR
    GARABEDIANRUFFALO, SM
    CHRETIEN, SD
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (7-8): : 575 - 580
  • [8] 9-YEAR EXPERIENCE WITH A PHARMACIST-MANAGED ANTICOAGULATION CLINIC
    CONTE, RR
    KEHOE, WA
    NIELSON, N
    LODHIA, H
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (10): : 2460 - 2464
  • [9] Cost-benefit-analysis of pharmacist-managed anticoagulation clinic for patients with atrial fibrillation
    Hanus, PM
    Evans-Shields, J
    Macri, T
    Turel, A
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : 518 - 518
  • [10] Pharmacist-managed headache clinic
    Weitzel, KW
    Presley, DN
    Showalter, ML
    Seymour, S
    Waddell, RF
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (23) : 2548 - 2550